Viral Hemorrhagic Fever

RSS feed

News Scan for Aug 23, 2016

Scallops test positive for hepatitis A as Hawaii outbreak grows

Food and Drug Administration (FDA) tests on scallops implicated in Hawaii's hepatitis A outbreak yielded positive results on two samples, according to an update yesterday from the agency on the investigation.

  • Hepatitis found in scallops
  • Fecal transplant trial
  • Meningitis C in Niger
  • Bagpipe lung
  • Experimental Ebola drug

News Scan for Aug 16, 2016

Study reveals better Ebola survival in patients with malaria co-infections

Patients infected with the Ebola virus were 20% more likely to survive if they were co-infected with malaria, according to a study of Liberians who received care at a treatment center in Monrovia in 2014 and 2015 during West Africa's outbreak. A research team led by the National Institute of Allergy and Infectious Diseases (NIAID) published the findings yesterday in Clinical Infectious Diseases.

  • Malaria may boost Ebola survival
  • Scallop hepatitis A source
  • Inhaled vs injectable flu vaccine
  • Camels and human cold virus
  • Venezuela malaria spike

News Scan for Aug 09, 2016

2014 Ebola strain no more viable than 1976 strain

A study yesterday in the Journal of Infectious Diseases suggests that although the Ebola outbreak originating in West Africa in 2013 was the deadliest to date, that strain of Ebola virus (EBOV) did not possess more aerosol stability than a strain of 1976 EBOV.

  • Aerosol stability in Ebola
  • HIV and drug-resistant TB
  • Global flu status
  • Campylobacter infection in children
  • Chikungunya update

News Scan for Jul 26, 2016

Flour recall expanded after 4 more E coli cases reported

General Mills expanded its recall of flour products yesterday after four more people in two states became sick with Escherichia coli infections.

  • E coli flour recall
  • Safety labels for fluoroquinolones
  • Antibiotic overuse for asthma
  • Ebola vaccine in monkeys

News Scan for Jul 25, 2016

WHO: Recent MERS cases linked to camels, healthcare settings

The Saudi Arabia Ministry of Health (MOH) reported two deaths from MERS-CoV (Middle East respiratory syndrome coronavirus) yesterday and today. The fatalities bring Saudi Arabia's total number of deaths from MERS-CoV since 2012 to 608.

  • Saudi MERS update
  • Ebola vaccine, viral shedding
  • New chikungunya cases

News Scan for Jul 18, 2016

Experiments shed light on how Zika viruses infect, cause birth defects

In the latest round of lab studies to pinpoint how Zika virus infects and causes birth defects in fetuses, researchers today reported several new clues related to the route and timing of infection, differences between the two viral strains, and even an antibiotic with the potential to block some of the damage.

  • Zika pregnancy lab findings
  • MERS family cluster probe
  • Ebola vaccine developments
  • HPV vaccine safety

News Scan for Jul 15, 2016

WHO: 73 more yellow fever cases in Angola, 491 more in DRC

In its weekly yellow fever situation report, the World Health Organization (WHO) today noted 73 more cases of the disease in Angola, bringing that country's suspected cases to 3,625.

  • Yellow fever spike
  • Neuro problems in Ebola
  • Preventing asymptomatic dengue
  • HIV, hepatitis, TB in prisoners

News Scan for Jul 13, 2016

FDA expands age indication for Prevnar 13 use in younger adults

The US Food and Drug Administration (FDA) has expanded the age indication for Pfizer's Prevnar 13, the pneumococcal 13-valent conjugate vaccine, allowing its use in adults ages 18 through 49 years old, the company said yesterday in a press release.

  • Prevnar 13 age indication expands
  • Predicting Rift Valley fever

News Scan for Jul 08, 2016

US reports first travel-linked Zika death

Utah health officials today announced the first known Zika death in the continental United States, in a Salt Lake County resident who died in late June.

  • US Zika death
  • More yellow fever in Angola
  • CDC Ebola recap
  • Resistance to MDR-TB drugs
  • Measles in Arizona

News Scan for Jul 05, 2016

Experimental antiviral trial launches in male Ebola survivors

US health officials and their Liberian counterparts today announced the launch of a study to assess if a new antiviral drug can cut lingering Ebola virus RNA levels in the semen of men who survived the disease, a strategy that could decrease the risk of sexual spread.

  • Ebola survivor drug study
  • MERS linked to camels
  • Reduced antibiotics
  • HPV and cervical abnormalities

Our underwriters